[How good are we really? Incidence of postoperative bleeding requiring intervention and intraoperative electrocoagulation during Thulium laser enucleation of the prostate].
Autor: | Filmar S; Abteilungen für Urologie, Asklepios Klinik Barmbek, Hamburg, Germany., Schaefer J; Asklepios Campus Hamburg, Semmelweis University of Medicine, Budapest, Hungary., Gross AJ; Abteilungen für Urologie, Asklepios Klinik Barmbek, Hamburg, Germany., Hook S; Abteilungen für Urologie, Asklepios Klinik Barmbek, Hamburg, Germany., Mehrer F; Abteilungen für Urologie, Asklepios Klinik Barmbek, Hamburg, Germany., Becker B; Abteilungen für Urologie, Asklepios Klinik Barmbek, Hamburg, Germany., Rosenbaum C; Abteilungen für Urologie, Asklepios Klinik Barmbek, Hamburg, Germany., Netsch C; Abteilungen für Urologie, Asklepios Klinik Barmbek, Hamburg, Germany. |
---|---|
Jazyk: | němčina |
Zdroj: | Aktuelle Urologie [Aktuelle Urol] 2024 Jun; Vol. 55 (3), pp. 228-235. Date of Electronic Publication: 2024 Apr 17. |
DOI: | 10.1055/a-2287-4987 |
Abstrakt: | The need for intervention due to postoperative bleeding represents a significant complication in Thulium Laser Enucleation of the Prostate (ThuLEP). This study aimed to retrospectively analyse this complication in the treatment of benign prostatic enlargement. This study focuses on investigating potential causative factors for postoperative bleeding requiring intervention as well as the use of intraoperative electrocoagulation. A total of 503 ThuLEP procedures performed between 08/2021 and 07/2022 were examined. Postoperatively, 4.2% (n=21) of patients experienced bleeding requiring intervention. Study data revealed a significant association between these instances of bleeding and a high prostate volume (p=0.004), high enucleation weight (p=0.004), and intraoperative electrocoagulation (p=0.048). In total, intraoperative electrocoagulation was applied in 41.2% (n=207) of cases. In these cases, statistically significant factors leading to the application of electrocoagulation included intraoperative capsule perforation (p=0.005) and high enucleation weight (p=0.002). Competing Interests: Die Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht. (Thieme. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |